Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Would you continue warfarin anticoagulation in patients with unprovoked DVT if switching to low-dose DOAC is cost-prohibitive?
Answer from: at Academic Institution
Would continue warfarin if this is cost-effective and doing well.
Sign in or Register to read more
Answer from: at Academic Institution
If switching to low dose DOAC is an option then could switching to ASA 81 also be an option? If not, I would continue warfarin as long as the patient has been able to maintain a therapeutic INR. I would not lower the INR range.
Sign in or Register to read more
16406
16467
Related Questions
How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?
What is your approach to infectious purpura fulminans?
How do you treat a patient with warfarin failure, with therapeutic INR 2-3 at the time of DVT, and no underlying malignancy or hypercoagulable state?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
Can you use apixaban or rivaroxaban in case of dabigatran failure?
Would you use PCC for clotting factor repletion in acute life threatening hemorrhage in a patient with elevated INR from coagulopathy of liver disease?
When should I consider anticoagulation in an unprovoked upper extremity deep venous thrombosis?
For a patient with ESRD on hemodialysis with recurrent AV fistula thrombosis and a finding of Protein C deficiency based on decreased plasma activity level on thrombophilia workup, what is recommended in terms of anticoagulation management?
What additional testing besides LAC/APLS, factor V Leiden, prothrombin gene mutation, JAK 2 do you draw for unprovoked cerebral venous sinus thrombosis?
Are SCDs contraindicated in patients with acute DVTs?